2031년까지의 유럽 생물공정 시장 전망 - 지역 분석 - 제품별(기기 및 소모품 및 액세서리), 운영 규모(상업 운영 및 임상 운영), 공정(하류 생물공정 및 상류 생물공정), 응용 분야(단일클론 항체, 백신, 재조합 단백질, 세포 및 유전자 치료 및 기타), 최종 사용자(생물제약 회사, 계약 제조 기관 및 기타)
성장하는 생물제약 산업이 유럽 생물공정 시장을 주도합니다
생물제약 산업에서 생물학적 제품, 세포 배양 적정 및 바이오시밀러 생산에서 새로운 규제 요구 사항, 품질 관리 요구 사항 및 생산 문제를 해결하기 위해 개선된 생물공정이 항상 요구됩니다. 최근 몇 년 동안 생물제약 산업은 전례 없는 속도로 성장해 왔습니다. 생물제약 회사는 다양한 치료적 응용 분야에 향상된 의학적 및 상업적 효능을 가진 새로운 분자를 도입하기 위해 R&D에 막대한 금액을 지출하고 있습니다. 생물공정의 수용은 생물학 및 바이오시밀러의 연구, 개발 및 제조에 광범위하게 적용되기 때문에 점차 증가하고 있습니다. 대형 제약 회사와 계약 연구 기관은 광범위한 증상을 치료하기 위한 새로운 의약품과 치료 형태를 내놓고 있습니다. 또한 만성 질환을 치료하기 위한 생물학적 제제와 바이오시밀러에 대한 강력한 수요가 바이오제약 산업의 성장을 견인하고 있습니다. 바이오제약 산업은 경제에 가장 큰 기여를 하는 산업 중 하나입니다. 생물학적 제제 승인 증가, 바이오시밀러 파이프라인 증가, 연구 활동에 대한 투자 증가, 저렴한 생물학적 제제 개발에 대한 집중 증가와 같은 요인이 바이오제약 산업의 성장을 촉진하고 있습니다.
이 외에도 유전자 및 세포 치료 승인 증가는 바이오프로세싱 시장 성장을 촉진하고 있습니다. 승인된 유전자 치료는 글리베라(지단백질 리파아제 결핍증 치료)와 스트림벨리스(ADA-중증 복합 면역 결핍증 치료)입니다. 따라서 위에서 언급한 요인은 다양한 치료제의 대량 생산에 대한 수요를 증가시켜 바이오프로세싱 시장의 성장을 촉진하고 있습니다.
유럽 생물공정 시장 개요
바이오시밀러는 경쟁을 도입하고 생물학적 제제의 경제성을 높여 궁극적으로 환자 치료와 의료 산업을 지원하기 위한 비용 절감과 부가가치 서비스를 제공합니다. 의료 전문가는 더 많은 환자를 더 저렴한 비용으로 고품질 생물학적 제제로 치료할 수 있습니다. 비용 절감의 엄청난 잠재력으로 인해 독일 보건부는 바이오시밀러 채택을 늘리기 위한 새로운 법률을 도입했습니다. 또한 국제 기업 간의 파트너십이 증가함에 따라 해당 국가의 시장 성장이 촉진되었습니다. 예를 들어, 2020년 11월 Hitachi Chemical Advanced Therapeutics Solutions, LLC와 apceth Biopharma GmbH는 Bluebird Bio와의 관계를 확대하여 여러 치료법의 임상 및 상업적 공급을 위한 장기 개발 및 제조 서비스 계약을 체결하고, 수혈 의존성 ?-탈라세미아(TDT)에 대한 일회성 유전자 요법인 ZYNTEGLO에 대한 유럽의 상업적 의약품 제조 용량을 확대했습니다. 또한, 독일의 생명공학 분야는 수많은 생명공학 기업, 첨단 연구 실험실, 막대한 연구 개발 자금 덕분에 엄청난 성장을 보이고 있습니다. 생물제약 및 생물학 분야의 연구 개발 성장은 주로 의료 산업의 기업들이 다양한 유기적 전략을 채택함으로써 주도되고 있습니다. 예를 들어, 2021년 6월, Rentschler Biopharma는 복합 항체에 대한 증가하는 수요를 충족하기 위해 2,000리터 생물 반응기로 생산 용량을 확장했습니다. 복합 항체는 지속적으로 높은 잠재력을 가진 생물제약 약물의 한 종류입니다. 마찬가지로, 2023년 8월, 생물제약 산업의 선도적 공급업체 중 하나인 Sartorius는 글로벌 기술 및 소프트웨어 리더인 Emerson과 협력하여 Sartorius의 Biostat STR Generation 3 생물 반응기 제품군을 Emerson의 DeltaVTM 분산 제어 시스템(DCS)과 통합했습니다. 따라서 생물제약 기업의 R&D 지출이 증가함에 따라 이 나라의 생물제약 분야가 성장하고 있습니다. 따라서, 국가의 생물제약 및 생명공학 기업의 협력적 연구 노력이 시장에 영향을 미칩니다.
2031년까지의 유럽 생물공정 시장 수익 및 예측(백만 달러)
유럽 생물공정 시장 세분화
유럽 생물공정 시장은 제품, 운영 규모, 공정, 응용 프로그램, 최종 사용자 및 국가로 분류됩니다.
제품을 기준으로 유럽 생물공정 시장은 기기와 소모품 및 액세서리로 나뉩니다. 기기 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다. 또한 기기 세그먼트는 여과 장치, 생물반응기, 크로마토그래피 시스템, 원심분리기, 건조 장치 등으로 세분화됩니다. 또한 생물반응기 하위 세그먼트는 파일럿 규모, 풀 스케일 및 실험실 규모로 분류됩니다. 또한 하위 세그먼트 크로마토그래피 시스템은 액체 크로마토그래피, 가스 크로마토그래피 등으로 세분화됩니다. 또한 소모품 및 액세서리 세그먼트는 시약, 세포 배양 배지, 크로마토그래피 수지 및 기타로 세분화됩니다.
운영 규모 측면에서 유럽 생물 처리 시장은 상업적 운영과 임상 운영으로 나뉩니다. 상업적 운영 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다.
프로세스별로 유럽 생물 처리 시장은 하류 생물 프로세스와 상류 생물 프로세스로 나뉩니다. 하류 생물 프로세스 세그먼트는 2023년에 더 큰 시장 점유율을 차지했습니다.
응용 프로그램을 기준으로 유럽 생물 처리 시장은 단일 클론 항체, 백신, 재조합 단백질, 세포 및 유전자 치료 및 기타로 분류됩니다. 단일 클론 항체 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.
최종 사용자 측면에서 유럽 생물 처리 시장은 생물 제약 회사, 계약 제조 기관 및 기타로 분류됩니다. 생물제약 회사 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.
국가별로 유럽 생물공정 시장은 독일, 프랑스, 이탈리아, 영국, 스페인 및 유럽의 나머지 지역으로 세분화됩니다. 독일은 2023년에 유럽 생물공정 시장 점유율을 지배했습니다.
Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc 및 Cytiva US LLC는 유럽 생물공정 시장에서 운영되는 주요 회사 중 일부입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Bioprocessing Market Landscape
4.1 Ecosystem Analysis
4.1.1 List of Vendors in the Value Chain
5. Europe Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:
6. Bioprocessing Market - Europe Analysis
6.1 Europe Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
7. Europe Bioprocessing Market Analysis - by Product
7.1 Overview
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
7.3.1 Overview
7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
8. Europe Bioprocessing Market Analysis - by Scale of Operation
8.1 Overview
8.2 Commercial Operations
8.2.1 Overview
8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
8.3.1 Overview
8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. Europe Bioprocessing Market Analysis - by Process
9.1 Overview
9.2 Downstream Bioprocess
9.2.1 Overview
9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
9.3.1 Overview
9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. Europe Bioprocessing Market Analysis - by Application
10.1 Overview
10.2 Monoclonal Antibodies
10.2.1 Overview
10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
10.3.1 Overview
10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
10.4.1 Overview
10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
10.5.1 Overview
10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. Europe Bioprocessing Market Analysis - by End User
11.1 Overview
11.2 Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
11.3.1 Overview
11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12. Europe Bioprocessing Market - Country Analysis
12.1 Europe
12.1.1 Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
12.1.1.1 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.2 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Germany: Bioprocessing Market Breakdown, by Product
12.1.1.2.1.1 Germany: Bioprocessing Market Breakdown, by Instruments
12.1.1.2.1.1.1 Germany: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.2.1.1.2 Germany: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.2.1.2 Germany: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.2.2 Germany: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.2.3 Germany: Bioprocessing Market Breakdown, by Process
12.1.1.2.4 Germany: Bioprocessing Market Breakdown, by Application
12.1.1.2.5 Germany: Bioprocessing Market Breakdown, by End User
12.1.1.3 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.4 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 United Kingdom: Bioprocessing Market Breakdown, by Product
12.1.1.4.1.1 United Kingdom: Bioprocessing Market Breakdown, by Instruments
12.1.1.4.1.1.1 United Kingdom: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.4.1.1.2 United Kingdom: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.4.1.2 United Kingdom: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.4.2 United Kingdom: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.4.3 United Kingdom: Bioprocessing Market Breakdown, by Process
12.1.1.4.4 United Kingdom: Bioprocessing Market Breakdown, by Application
12.1.1.4.5 United Kingdom: Bioprocessing Market Breakdown, by End User
12.1.1.5 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Overview
12.1.1.6 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 France: Bioprocessing Market Breakdown, by Product
12.1.1.6.1.1 France: Bioprocessing Market Breakdown, by Instruments
12.1.1.6.1.1.1 France: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.6.1.1.2 France: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.6.1.2 France: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.6.2 France: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.6.3 France: Bioprocessing Market Breakdown, by Process
12.1.1.6.4 France: Bioprocessing Market Breakdown, by Application
12.1.1.6.5 France: Bioprocessing Market Breakdown, by End User
12.1.1.7 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.7.1 Overview
12.1.1.8 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.8.1 Italy: Bioprocessing Market Breakdown, by Product
12.1.1.8.1.1 Italy: Bioprocessing Market Breakdown, by Instruments
12.1.1.8.1.1.1 Italy: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.8.2 Italy: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.8.2.1 Italy: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.8.3 Italy: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.8.4 Italy: Bioprocessing Market Breakdown, by Process
12.1.1.8.5 Italy: Bioprocessing Market Breakdown, by Application
12.1.1.8.6 Italy: Bioprocessing Market Breakdown, by End User
12.1.1.9 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.9.1 Overview
12.1.1.10 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.10.1 Spain: Bioprocessing Market Breakdown, by Product
12.1.1.10.1.1 Spain: Bioprocessing Market Breakdown, by Instruments
12.1.1.10.1.1.1 Spain: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.10.1.1.2 Spain: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.10.1.2 Spain: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.10.2 Spain: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.10.3 Spain: Bioprocessing Market Breakdown, by Process
12.1.1.10.4 Spain: Bioprocessing Market Breakdown, by Application
12.1.1.10.5 Spain: Bioprocessing Market Breakdown, by End User
12.1.1.11 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.11.1 Overview
12.1.1.12 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.12.1 Rest of Europe: Bioprocessing Market Breakdown, by Product
12.1.1.12.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Instruments
12.1.1.12.1.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.12.1.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.12.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.12.2 Rest of Europe: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.12.3 Rest of Europe: Bioprocessing Market Breakdown, by Process
12.1.1.12.4 Rest of Europe: Bioprocessing Market Breakdown, by Application
12.1.1.12.5 Rest of Europe: Bioprocessing Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Corning Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 3M Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Eppendorf SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Entegris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Agilent Technologies Inc
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Cytiva US LLC
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
?
List of Tables
Table 1. Europe Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 35. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 36. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 37. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 38. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 39. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 40. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 41. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 42. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 43. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 44. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 45. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 46. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 47. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 48. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 49. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 50. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 51. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 52. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 53. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 54. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 55. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 56. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 57. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 58. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 59. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 60. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. Europe Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Europe: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Repligen Corp
- Entegris Inc
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.